Dr. James Strauss
Claim this profileMary Crowley Cancer Research
About James Strauss
Education:
- Obtained a B.A. (Bachelor of Arts) from Harvard University in 1968.
- Earned an M.D. (Doctor of Medicine) from New York University School of Medicine in 1972.
Experience:
- Completed an Internship in Medicine at Los Angeles County University of Southern California Medical Center in 1973.
- Serves as Clinical Scientific Director at Mary Crowley Cancer Research, leading and developing innovative clinical trials for cancer patients.
Area of expertise
Cancer
James Strauss has run 12 trials for Cancer. Some of their research focus areas include:
Solid Tumors
James Strauss has run 7 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Mary Crowley Cancer Research
Mary Crowley Cancer Research Center
Clinical Trials James Strauss is currently running
EU101
for Solid Cancers
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Recruiting
1 award
Phase 1 & 2
10 criteria
AdAPT-001
for Cancer
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Recruiting
1 award
Phase 2
17 criteria
More about James Strauss
Clinical Trial Related
4 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments James Strauss has experience with
- PD-1 Inhibitor
- Pembrolizumab
- CAB-AXL-ADC
- Nivolumab
- Surufatinib
- ON123300
Breakdown of trials James Strauss has run
Cancer
Solid Tumors
Tumors
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Strauss specialize in?
James Strauss focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is James Strauss currently recruiting for clinical trials?
Yes, James Strauss is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that James Strauss has studied deeply?
Yes, James Strauss has studied treatments such as PD-1 inhibitor, Pembrolizumab, CAB-AXL-ADC.
What is the best way to schedule an appointment with James Strauss?
Apply for one of the trials that James Strauss is conducting.
What is the office address of James Strauss?
The office of James Strauss is located at: Mary Crowley Cancer Research, Dallas, Texas 75230 United States. This is the address for their practice at the Mary Crowley Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.